title: [Mucosa-associated lyphoid tissue hepatic lymphoma with low-grade malignancy associated with primary biliary cirrhosis].
authors.forename: Lamia
authors.initials: L
authors.lastname: Golli
authors.forename: Julien
authors.initials: J
authors.lastname: Taïeb
authors.forename: Emmanuel
authors.initials: E
authors.lastname: Boleslawski
authors.forename: Frédéric
authors.initials: F
authors.lastname: Charlotte
authors.forename: Jacques
authors.initials: J
authors.lastname: Taboury
authors.forename: Vincent
authors.initials: V
authors.lastname: di Martino
authors.forename: Thierry
authors.initials: T
authors.lastname: Poynard
authors.forename: Laurent
authors.initials: L
authors.lastname: Hannoun
mesh_terms: D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D005260:Female; D005500:Follow-Up Studies; D006651:Histocytochemistry; D006801:Humans; D007165:Immunosuppression Therapy; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008099:Liver / Q000473:pathology; D008105:Liver Cirrhosis, Biliary / Q000150:complications* / Q000601:surgery; D008113:Liver Neoplasms / Q000150:complications* / Q000175:diagnosis / Q000473:pathology / Q000601:surgery; D016031:Liver Transplantation; D018442:Lymphoma, B-Cell, Marginal Zone / Q000150:complications* / Q000175:diagnosis / Q000473:pathology / Q000601:surgery; D008875:Middle Aged; D011241:Prednisone / Q000627:therapeutic use; D016559:Tacrolimus / Q000627:therapeutic use; D013997:Time Factors
chemical_list: D000893:Anti-Inflammatory Agents; D007166:Immunosuppressive Agents; D011241:Prednisone; D016559:Tacrolimus